+689.7%
MRNA vs IONS
-62.4%
+752.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | IONS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -4.8% | +1.6% | -6.4% | -5.8% |
| 7D | -20.9% | -3.3% | -17.6% | -19.4% |
| 30D | -13.3% | -38.3% | +25.0% | +14.2% |
| 3M | +212.6% | -54.1% | +266.6% | +418.3% |
| 6M | +309.0% | -62.2% | +371.3% | +566.1% |
| YTD | +567.3% | -65.4% | +632.7% | +1,038.6% |
| 1Y | +689.7% | -63.2% | +752.9% | +1,198.9% |
| All | +689.7% | -62.4% | +752.1% | +1,198.9% |
Cumulative growth
Daily Returns
Daily percentage return beside IONS.
Daily Out/Under-Performance
Portfolio return minus IONS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × IONS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded IONS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling